Call for Papers:Vol.11 Issue.3

Submission
Last date		 28-Jun-2025
Acceptance Status In One Day
Paper Publish In Two Days
Submit ManuScript

News & Updates

Submit Article

Dear Authors, Article publish in our journal for Volume-11,Issue-3. For article submission on below link: Submit Manuscript


Join As Board

Dear Reviewer, You can join our Reviewer team without given any charges in our journal. Submit Details on below link: Join As Board


Paper Publication Charges

IJARIIE APP
Download Android App

For Authors

Archives

IJARIIE Board

Downloads

Android App

Download IJARIIE APP

Authors

Title: :  Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A
PaperId: :  20344
Published in:   International Journal Of Advance Research And Innovative Ideas In Education
Publisher:   IJARIIE
e-ISSN:   2395-4396
Volume/Issue:    Volume 9 Issue 3 2023
DUI:    16.0415/IJARIIE-20344
Licence: :   IJARIIE is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Author NameAuthor Institute
Sanaullah SafiCheragh Medical Institute of Higher Education
Hedayaturahman HabibzaiMili Institute of Higher Education
sayed tariq PachakhanSpinghar Medical Institute

Abstract

life Sciences
Hemophilia A, Gene Therapy, FIII, Valoctocogene Roxaparvovec (Roctavian), Adeno-Associated Virus (AAV), BioMarin Pharmaceutical Inc
Hemophilia is a hemorrhagic disease characterized by the absence or deficiency of clotting factor VIII (hemophilia A) or clotting factor IX (hemophilia B) and hemophilia C or factor XI deficiency. It affects 1 in 5,000 living males, 1 in 40,000 live males, and 1 in 100,000 live births worldwide (Hemophilia A, B, and C). Emicizumab is a monoclonal antibody that bridges activated factors IX and X to perform the duties of activated factor VIII when it is absent, restoring hemostasis. Intravenous infusion of exogenous FVIII is the current gold standard in hemophilia A treatment. Prophylactic coagulation factor replacement has been shown to reduce arthropathy, decrease the frequency of bleeds, and improve quality of life. Gene therapy for hemophilia involves targeting hepatocytes, allowing for long-term expression of defective FVIII while maintaining stable plasma FVIII concentrations. The first gene therapy for hemophilia A is Roctavian. Valoctocogene roxaparvovec, the active ingredient in Roctavian, is based on an adeno-associated virus (AAV) that has been altered not to infect people. Roxaparvovec was granted conditional marketing authorization in the EU to treat severe hemophilia A in adults without FVIII inhibitors and AAV5 antibodies.

Citations

Copy and paste a formatted citation or use one of the links to import into a bibliography manager and reference.

IJARIIE Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A" International Journal Of Advance Research And Innovative Ideas In Education Volume 9 Issue 3 2023 Page 2150-2157
MLA Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal Of Advance Research And Innovative Ideas In Education 9.3(2023) : 2150-2157.
APA Sanaullah Safi, Hedayaturahman Habibzai, & sayed tariq Pachakhan. (2023). Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A. International Journal Of Advance Research And Innovative Ideas In Education, 9(3), 2150-2157.
Chicago Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal Of Advance Research And Innovative Ideas In Education 9, no. 3 (2023) : 2150-2157.
Oxford Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. 'Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A', International Journal Of Advance Research And Innovative Ideas In Education, vol. 9, no. 3, 2023, p. 2150-2157. Available from IJARIIE, https://ijariie.com/AdminUploadPdf/Understanding_of_Valoctocogene_Roxaparvovec__Roctavian__as_a_Breakthrough_Gene_Therapy_for_Hemophilia_Type_A_ijariie20344.pdf (Accessed : 06 December 2024).
Harvard Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. (2023) 'Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A', International Journal Of Advance Research And Innovative Ideas In Education, 9(3), pp. 2150-2157IJARIIE [Online]. Available at: https://ijariie.com/AdminUploadPdf/Understanding_of_Valoctocogene_Roxaparvovec__Roctavian__as_a_Breakthrough_Gene_Therapy_for_Hemophilia_Type_A_ijariie20344.pdf (Accessed : 06 December 2024)
IEEE Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan, "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A," International Journal Of Advance Research And Innovative Ideas In Education, vol. 9, no. 3, pp. 2150-2157, May-Jun 2023. [Online]. Available: https://ijariie.com/AdminUploadPdf/Understanding_of_Valoctocogene_Roxaparvovec__Roctavian__as_a_Breakthrough_Gene_Therapy_for_Hemophilia_Type_A_ijariie20344.pdf [Accessed : 06 December 2024].
Turabian Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. "Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A." International Journal Of Advance Research And Innovative Ideas In Education [Online]. volume 9 number 3 (06 December 2024).
Vancouver Sanaullah Safi, Hedayaturahman Habibzai, and sayed tariq Pachakhan. Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type A. International Journal Of Advance Research And Innovative Ideas In Education [Internet]. 2023 [Cited : 06 December 2024]; 9(3) : 2150-2157. Available from: https://ijariie.com/AdminUploadPdf/Understanding_of_Valoctocogene_Roxaparvovec__Roctavian__as_a_Breakthrough_Gene_Therapy_for_Hemophilia_Type_A_ijariie20344.pdf
BibTex EndNote RefMan RefWorks

Number Of Downloads


Last download on 12/6/2024 4:44:17 PM

Save in Google Drive

Similar-Paper

TitleArea of ResearchAuther NameAction
Evaluation of the nutritional and sensory attributes of two aromatic rices varietes from northern Madagascar "Mogodro and Madame Rose"Biological SciencesRahanitrarivony Veronirina Download
Assessing the Impact of Comprehensive Chromosome Screening in Preimplantation Genetic Testing for Aneuploidy: A Meta-Analytical ReviewBiotechnologyAnindita Kundu Download
Expansion of biosimilars in indian pharmaceutical marketBiotechnologyVadi Aryan Download
Advanced Doctorate of Philosophy Seven Months Diploma in Bio-Eco-Bio cum Bio-Eco-Bio Biotechnological Bio-Eco-Bio Plant Sciences cum Advanced & Applied Bio Plant Sciences (Bio-Eco-Bio Edible Herbal) With Second PreceedingBiogeosciences Amit Rastogi Download
Polycystic Ovary Syndrome Prediction [ML]Information Technology EngineeringChavan Ganesh Baban Download
Role of Nutrition in Chronic Kidney DiseaseFood science and NutraceuticalMs. Tanvi Sunil Ballal Download
Understanding of Valoctocogene Roxaparvovec (Roctavian) as a Breakthrough Gene Therapy for Hemophilia Type Alife Sciences Sanaullah Safi Download
Overview of artificial intelligence and NanoroboticsPharmacyKakade Swati babasaheb Download
Studies on Extraction of Flavonoids from Leaves of Artocarpus heterophyllusBiotechnologyAnsh Aggarwal Download
NANOMEDICINES IN NANOTECHNOLOGYPharmacyMohammad Shoab Shaikh Diler Download
A Study of Pseudomonas Bio Control Strains for Environmental Bio Control Inoculants ApplicationsBIOTECHNOLOGYDr. Sudhir Kumar Mishra Download
A Study of Genomics and Metabolic Reconstructions with Pseudomonas from Biotechnology BiotechnologyDr. Sudhir Kumar Mishra Download
A Study of Creation of Tailor-Made Synthetic Properties Pseudomonas Putida in Bacterial HostBIOTECHNOLOGYDr. Sudhir Kumar Mishra Download
A Study of Recent Advances in Systems Biology of Pseudomonas in BiotechnologyBiotechnologyDr. Sudhir Kumar Mishra Download
A Study of Pseudomonas Putida of Core Carbon and Energy Metabolism in BiotechnologyBIOTECHNOLOGYDr. Sudhir Kumar Mishra Download
12